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AbstRACt: Hepatectomy has been the standard treatment for metachronic metastases of non-colorectal (NCR) origin, mainly 
when the disease-free interval is more than two years. Laparoscopic hepatectomy has become the golden standard mainly for left 
side resections, due to lower morbidity, shorter hospital stay, early recovery and good cosmetic outcome. the authors report the case 
of a female patient with two metachronic metastases (ten years of disease-free survival), of non-colorectal origin (adenocarcinoma of 
small intestine), treated by laparoscopic left lateral segmentectomy (left hepatic lobectomy) with success. the postoperative progress 
was satisfactory. to date, the patient has presented no tumoral recurrence (six months of follow-up period).  Laparoscopic left lateral 
segmentectomy can be satisfactorily performed in selected cases of hepatic metastasis. this approach presents low morbidity and good 
cosmetic result. The lack of alternative treatments and the poor prognosis of untreated cases have justified surgical resection in order 
to increase overall survival. Nevertheless, this approach should be performed by hepatic surgery expertise teams trained on advanced 
laparoscopic procedures.  
Keywords: laparoscopy; colorectal neoplasm; hepatectomy; neoplasm metastasis; liver neoplasm/surgery; liver neoplasm/secondary; 
survival rate.
Laparoscopic left lateral segmentectomy for metachronic metastases 
of small intestine adenocarcinoma: a case report
seRgio Renato Pais-Costa1, seRgio Luiz MeLo aRaujo2, oLíMPia aLves teixeiRa LiMa3, 
MaRCio aLMeida Paes4, sandRo josé MaRtins5
1In Doctor’s Degree Program, Universidade Federal de São Paulo (UNIFESP) – São Paulo (SP), Brazil; Oncologic 
Surgeon Physician, Hospital Santa Lucia  – Brasília (DF), Brazil. 2Specialist in General Surgery; General Surgeon and 
Physician of the Hospital Santa Lucia  – Brasília (DF), Brazil. 3Assistant Professor of Surgery at the Universidade de 
Brasília (UNB) – Brasilia (DF), Brazil; General Surgeon and Physician of the Hospital Santa Lucia  – Brasília (DF), 
Brazil. 4Head of the Clinical Oncology Service of the Hospital de Base do Distrito Federal – Brasília (DF), Brazil; 
Oncologist at the Hospital Santa Lucia  – Brasília (DF), Brazil. 5Adjunct Professor of Oncology at the Universidade de 
Brasilia (UNB); Oncologist at the Hospital Santa Lucia  – Brasília, (DF), Brazil.
Study carried out at the Hospital Santa Lucia – Brasília (DF), Brazil. 
Financing source: none. 
Conflict of interest: nothing to declare.
Submitted on: 09/30/2010 
Approved on: 10/21/2011
INtRODUCtION
Hepatectomy has been selected as the curative 
treatment of choice for metastases of colorectal (CR) 
origin. in a systematic review recently published by 
simmonds et al.1, the survival rates in 5 years in 16 se-
ries, including R0 resection only, range from 15 to 67%, 
median of 30%. in the same study, postoperative mor-
tality ranged from 0 to 6.6%, median of 3%. then, the 
deeper knowledge of anatomy and surgery technique, 
combined with the increasingly improved support con-
ditions, both in the intraoperative and postoperative pe-
riods, has lead to substantially reduced mortality in this 
operation1. in parallel, due to developments in hepatic 
surgery, hepatectomy has been freely indicated for the 
treatment of CR metastases, where resection is the only 
way of healing or extended survival1-7. More recently, 
several series in the literature have also demonstrated 
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satisfactory results in the resection of non-colorectal 
(nCR) metastases. the results, when the nCR metasta-
ses resection is performed in selected cases, are similar 
to those observed in CR metastases resection, with rates 
in a 5-year survival ranging from 20 up to 45%8-13. in 
our community, the author of this study, in a prior study 
that compared CR and nCR metastases, observed si-
milar survival, of around 20%, in a 5-year survival for 
the two groups7. Literature shows that this practice has 
been more freely adopted, especially when the disease 
remains exclusively confined to the liver, limited to one 
lobe, and mainly when the disease-free survival (dFs) 
between the primary tumor treatment and the distant le-
sion presentation is more than two years8-13.
today, laparoscopic resection of metastases has 
become a reality, especially for lesions in the left he-
patic lobe, as it is technically easier to be performed 
using this access. Laparoscopic hepatectomy (LH) 
offers many advantages in relation to the open surgery, 
such as lower morbidity, shorter hospital stay, reduced 
postoperative pain, reduced bleeding, reduced trans-
fusion, early return to habitual activities, early feeding 
and good cosmetic outcome. Recent studies show that, 
in an oncologic perspective, LH does not show any 
difference in terms of recurrence, margins or survival 
when compared to the open technique if the principles 
of radicality are maintained14-29. 
the authors describe the case of a young fema-
le patient with two metachronic metastases (ten years 
of disease-free survival) in the left hepatic lobe (seg-
ments ii-iii), originated from an adenocarcinoma of 
small intestine (terminal ileum), who was submitted 
to a laparoscopic left lateral segmentectomy (left he-
patic lobectomy – segments ii+iii) with success. the 
postoperative progress was excellent, with six-month 
disease-free survival so far. 
CAsE REPORt
a 42-year-old female patient was submitted to a 
partial enterectomy in the terminal ileum (20-cm re-
section) with primary entero-entero anastomosis due 
to an adenocarcinoma of small intestine (tnM sta-
ging – t2n0M0) ten years before. no adjuvant treat-
ment was performed at the time, with periodic exami-
nations. in the routine exams, the abdominal control 
computed tomography showed two 3 cm metastases 
in the left hepatic lobe (segments ii-iii). the patient 
was in excellent conditions in general, with no sign 
of clinical or radiological extrahepatic dissemination. 
staging was complemented with magnetic resonan-
ce of the abdomen, which showed these lesions only 
(Figure 1). a Pet-sCan (positron emission tomo-
graphy) was also performed, which confirmed an ex-
clusively hepatic disease. the serum dosage of carci-
noembryonic antigen was 41.2 ng/mL. as the patient 
had two small metastases confined to the left lobe and 
she presented a long disease-free period (ten years be-
tween the enterectomy and the presentation of hepatic 
lesions), the surgical resection was proposed. the la-
paroscopic procedure was suggested, which has been 
the medical team’s choice to treat lesions in the left 
hepatic lobe. Five trocars were used, and their sites 
are illustrated in Figure 2. in the abdominal cavity 
evaluation, no sign of distant dissemination was ob-
served. Laparoscopic left lateral segmentectomy was 
then successfully performed, without interoccurren-
ces, using the intrahepatic glissonian access techni-
que, as described by Machado et al.29. no clamping of 
the liver hilum (Pringle maneuver) was performed. a 
hemostatic 10 mm LigaSure jaw (Valleylab, USA) for 
parenchyma sectioning and a white-loaded endoscopic 
stapler, of vascular type (Endogia 45 mm, Ethicon), 
for the left hilar elements and left hepatic vein. 
Figure 1. Nuclear magnetic resonance of the abdomen showing 
two lesions of 3 cm in the left lobe, segments II-III.
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the specimen was removed into an endo-
bag, closed and without contamination, through a 
small median incision at the previous surgery site 
(Figures 2 and 3). the patient was fed on the same 
day (12 hours after the surgery). she did not receive 
blood, only dipyrone, as an analgesic substance. she 
presented good progress, without interoccurrences 
and was discharged from hospital on the third day af-
ter the surgery. the histopathological exam showed 
only two lesions with metastatic adenocarcinoma 
and neoplasm-free margins. no adjuvant treatment 
was indicated, only periodic exams. six months after 
the surgery, the patient showed no symptoms and no 
disease recurrence.
DIsCUssION
the resection of nCR metastases has been con-
sidered the standard curative treatment in selected ca-
ses. Several series have shown the benefit of resection 
when compared to alternative palliative treatments, 
such as systemic chemotherapy. only resection can 
offer the real chance of healing or extended survival. 
However, the proper selection seems to be the main 
rationale of resection. then, factors such as: patient’s 
good conditions in general; proper nutritional and he-
patic reserves; exclusively hepatic lesion; long disea-
se-free survival between the primary tumor treatment 
and the presentation of metastases; and the nCR me-
tastases etiology itself, seem to be the most important 
prognostic criteria for long-time survival observed in 
the literature7-13. 
Laurent et al.12, when evaluating a series of 39 
patients submitted to surgery due to nCR metastases 
with zero mortality, observed global survival of 35% 
in the 8-year period. only the disease-free survival 
(dFs) over 24 months was a positive prognostic fac-
tor for long-term survival at the multivariate analysis 
(Mva). the primary tumor origin, such as gastrointes-
tinal tract (git), genitourinary tract (gut) or others 
(sarcomas, breast, melanoma, etc.), was not a crite-
rion of poor prognosis through the Mva. Weitz et al.9, 
in a study that analyzed a series of 141 patients from 
the Memorial sloan Kettering Cancer Center, in new 
York (zero mortality and 33% morbidity), observed 
that the main factors of good prognosis at the Mva 
were dFs over 24 months and primary tumor etiology 
Figure 2. Sites of trocar utilization. Incision for specimen 
removal.
Figure 3. Left lateral sectorectomy. Note the two metastases in 
segments II-III (2 cm margin).
(tumor of reproductive system). However, Hemming 
et al.13, in toronto, Canada, evaluating a series a 37 
patients whose postoperative mortality was also zero, 
reported 45% survival in a 5-year period; at the Mva, 
no statistically significant difference was observed 
when compared to the dFs over 36 months. the only 
two predictive factors of better survival were: origin 
of non-gastrointestinal primary tumor (ngit) and ne-
oplasm-free margins.
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ercolani et al.11, in an italian study that 
analyzed 83 cases of resection, observed 34% survi-
val in a 5-year period, also with zero postoperative 
mortality, while morbidity was 20%. at the Mva, 
they found only the tumor volume as a prognostic 
factor for recurrence (metastasis volume larger than 
125 cc), although the dFs over one year showed a 
tendency towards that, but without significance due 
to the sample size. Specifically when the subgroup 
of operated primary tumor was analyzed, a statis-
tically significant different was observed between 
metastases from git versus gut tumors, sarcomas 
or even breast. For git tumors, survival was lower 
than in the others, with 17.3% in 3 years, and 8.4% 
in 5 years, respectively.
in our community, the author of this study, in a 
previously published case that analyzed ten patients 
submitted to resection of metachronic metastases of 
nCR (dFs over one year), observed 50% survival in 
a 3-year period, with zero mortality in the hepatec-
tomies performed8. in another previous study of the 
same author, in which ten patients with nCR metas-
tasis were compared to a similar contemporaneous 
cohort of 20 patients with nCR metastasis, all of 
them submitted to hepatic resection (all cases opera-
ted by the same medical team), no statistically signi-
ficant difference was observed for survival between 
the two groups. the criteria of poor prognosis at the 
Mva in both groups (CR and nCR metastases) were: 
lymph node involvement (in hepatic hilum or prima-
ry tumor) and more than one metastasis7.
Finally, in the study of greater number of ca-
ses found in the literature (although multicenter and 
retrospective), adam et al.10, when evaluating 1,452 
patients submitted to resection due to nCR metas-
tases, observed 36% overall survival in a 5-year 
period (23% in 10-year survival), associated with 
2.3% overall mortality and 21.5% morbidity. they 
found, at the Mva, the following factors of poor 
prognosis: age over 60 years, primary tumor that is 
not breast or melanoma cancer, squamous cells in 
the histological study (epidermoid carcinoma), dFs 
lower than one year, extra-hepatic disease, resec-
tion with positive margin and larger hepatectomy. 
these authors also described a score, with a mathe-
matical model, that can predict survival based on 
these prognostic factors. in addition, they sorted the 
patients according to the Mva and evaluated their 
long-term survival. then, the patients were classi-
fied according to this score as: low risk (score 0–3, 
46% survival in a 5-year period), medium risk (sco-
re 4–6, 33% survival in a 5-year period) and high 
risk (score over 6, survival in a 5-year period lower 
than 10%).
When applying this mathematical model to this 
case, the patient would be classified as low risk, com-
bined with her excellent nutritional condition, absence 
of comorbidities and good hepatic reserve, facts that 
influenced the selection of resection.
With the development in laparoscopic surgery 
in general, laparoscopic hepatectomy (LH) has been 
more freely indicated for the treatment of both benign 
and malign hepatic neoplasms. advantages, such as 
reduced intraoperative bleeding, lower morbidity, 
shorter hospital stay, early recovery and good cos-
metic outcome, have been constantly observed14-29. 
For left-side resections, recently published control-
led studies have suggested laparoscopy as the fa-
vorite method especially of experienced surgeons 
in laparoscopic hepatic surgery15,16. this fact also 
influenced the decision on the access method used 
in this study, as 20 LHs have been performed by the 
medical team (for both benign and malign tumors) 
in the last four years30. 
on the other hand, regarding the treatment of 
malign neoplasm, recent studies have suggested that 
there is no difference between LH and open hepatec-
tomy to treat metastases in portals, margins, local-
systemic recurrence or long-term survival20,22,23,26,27. 
in our community, Machado et al.24, in a small series 
of four patients with CR metastasis submitted to LH, 
have already demonstrated the benefit of LH, which 
was performed with effectiveness and safety. in a re-
view in the national literature, however, no case of 
LH used in the treatment of nCR metastasis has been 
found to date.
this case shows that, when well indicated and 
performed by a team with expertise in hepatic sur-
gery, particularly in laparoscopic procedures, LH 
can be an excellent therapeutic option. LH offers 
innumerous advantages (lower morbidity, reduced 
postoperative pain, early recovery and good cos-
metic outcome), without compromising the onco-
logic radicality.
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REsUmO: A hepatectomia tem sido o tratamento padrão para metástase de origem não colorretal (NCR) metacrônica, principal-
mente quando o intervalo livre de doença é maior do que dois anos. A hepatectomia por laparoscopia tem se tornado padrão prin-
cipalmente para as ressecções à esquerda, haja vista a menor morbidade, menor tempo de internação, reabilitação precoce e melhor 
resultado estético. Os autores relatam um caso de paciente com duas metástases metacrônicas (10 anos de sobrevida livre de doença), 
de etiologia não colorretal (adenocarcinoma de intestino delgado), tratada com segmentectomia lateral esquerda (lobectomia hepática 
esquerda) laparoscópica. Paciente apresentou boa evolução pós-operatória sem recidiva (seis meses de seguimento). segmentectomia 
lateral esquerda laparoscópica pode ser satisfatoriamente realizada em casos selecionados de metástases hepáticas, acarretando menor 
morbidade e melhor resultado estético. A falta de tratamentos alternativos e o prognóstico reservado nos casos de metástases NCR não 
operadas justificam a ressecção com o objetivo de prolongar a sobrevida. No entanto, essa abordagem deve ser realizada por equipe es-
pecializada em cirurgia hepática com treinamento em procedimentos laparoscópicos avançados.
Palavras-chave: laparoscopia; neoplasias colorretais; hepatectomia; metástase neoplásica; neoplasias hepáticas/cirurgia; neoplasias 
hepáticas/secundário; taxa de sobrevida.
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Laparoscopic left lateral segmentectomy (left he-
patic lobectomy) can be satisfactorily performed in se-
lected cases of hepatic metastasis, with lower morbi-
dity and good cosmetic result. the lack of alternative 
treatments and the poor prognosis of untreated cases 
of NCR metastasis have justified surgical resection in 
order to increase overall survival. nevertheless, this 
approach should be performed by hepatic surgery 
expertise teams trained on advanced laparoscopic 
procedures.
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